EP1599494A4 - Wiederherstellung der funktion von mutanten des gonadotropin-freisetzungshormonrezeptors - Google Patents

Wiederherstellung der funktion von mutanten des gonadotropin-freisetzungshormonrezeptors

Info

Publication number
EP1599494A4
EP1599494A4 EP04705679A EP04705679A EP1599494A4 EP 1599494 A4 EP1599494 A4 EP 1599494A4 EP 04705679 A EP04705679 A EP 04705679A EP 04705679 A EP04705679 A EP 04705679A EP 1599494 A4 EP1599494 A4 EP 1599494A4
Authority
EP
European Patent Office
Prior art keywords
hormone receptor
releasing hormone
gonadotropin releasing
restoring function
receptor mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04705679A
Other languages
English (en)
French (fr)
Other versions
EP1599494A2 (de
Inventor
P Michael Conn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Publication of EP1599494A2 publication Critical patent/EP1599494A2/de
Publication of EP1599494A4 publication Critical patent/EP1599494A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP04705679A 2003-01-29 2004-01-27 Wiederherstellung der funktion von mutanten des gonadotropin-freisetzungshormonrezeptors Withdrawn EP1599494A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44369103P 2003-01-29 2003-01-29
US443691P 2003-01-29
PCT/US2004/002290 WO2004069859A2 (en) 2003-01-29 2004-01-27 Restoring function to gonadotropin releasing hormone receptor mutants

Publications (2)

Publication Number Publication Date
EP1599494A2 EP1599494A2 (de) 2005-11-30
EP1599494A4 true EP1599494A4 (de) 2010-01-06

Family

ID=32850796

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04705679A Withdrawn EP1599494A4 (de) 2003-01-29 2004-01-27 Wiederherstellung der funktion von mutanten des gonadotropin-freisetzungshormonrezeptors

Country Status (4)

Country Link
EP (1) EP1599494A4 (de)
AU (1) AU2004208990B2 (de)
CA (1) CA2514449A1 (de)
WO (1) WO2004069859A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
ES2585584T3 (es) * 2009-05-26 2016-10-06 Amicus Therapeutics, Inc. Utilización de chaperonas farmacológicas para mejorar la fabricación y la purificación de ß-glucosidasa ácida

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038036A2 (en) * 2001-10-09 2003-05-08 Oregon Health & Science University Rescue of gonadotropin releasing hormone receptor mutants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038036A2 (en) * 2001-10-09 2003-05-08 Oregon Health & Science University Rescue of gonadotropin releasing hormone receptor mutants

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CONN P MICHAEL ET AL: "Protein origami: therapeutic rescue of misfolded gene products.", MOLECULAR INTERVENTIONS SEP 2002, vol. 2, no. 5, September 2002 (2002-09-01), pages 308 - 316, XP002556613, ISSN: 1543-2548 *
JANOVICK J A ET AL: "Structure-Activity Relations of successful Pharmacologic Chaperones for rescue of Naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 305, no. 2, 11 February 2003 (2003-02-11), pages 608 - 614, XP008107968, ISSN: 0022-3565 *
JANOVICK, JO ANN ET AL: "Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM , 87 (7), 3255 -3262 CODEN: JCEMAZ; ISSN: 0021-972X, 2002, XP002960366 *
LEANOS-MIRANDA ALFREDO ET AL: "Receptor-misrouting: An unexpectedly prevalent and rescuable etiology in GnRHR-mediated hypogonadotropic hypogonadism", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 87, no. 10, October 2002 (2002-10-01), pages 4825 - 4828, XP002556612, ISSN: 0021-972X *

Also Published As

Publication number Publication date
AU2004208990B2 (en) 2010-11-11
CA2514449A1 (en) 2004-08-19
WO2004069859A2 (en) 2004-08-19
WO2004069859A3 (en) 2009-04-02
EP1599494A2 (de) 2005-11-30
AU2004208990A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
AU2003284402A1 (en) Antagonist to melanin-concentrating hormone receptor
EP1537880A4 (de) PRûPARAT MIT VERZ GERTER FREISETZUNG
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU6808901A (en) Adenosine a2a receptor antagonists
LT2662390T (lt) Interferono-alfa receptoriaus-1 antikūnai ir jų panaudojimas
EP1653960A4 (de) Melanin-konzentrierender hormonrezeptor-antagonist
IL196384A0 (en) Corticotropin releasing factor 2 receptor agonists
AU2003285540A8 (en) Antibody for the thyrotropin receptor and uses thereof
AU2003260803A8 (en) Sustained release pharmaceutical composition
EP1778278A4 (de) Gonadotropin-releasing-hormon-antagonisten
IL163887A0 (en) Controlled release dosage forms
EP1478353A4 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung
IL173337A0 (en) Receptor
EP1599494A4 (de) Wiederherstellung der funktion von mutanten des gonadotropin-freisetzungshormonrezeptors
AU1252102A (en) Receptor
GB0000474D0 (en) Receptor
AU2001275362A1 (en) Nuclear hormone receptors
GB0327724D0 (en) Gated image intensifier
AU2003242852A1 (en) Nuclear hormone receptor
AU2003213801A8 (en) Toll-like receptor 11
AU2003242849A8 (en) Nuclear hormone receptor
ZA200404994B (en) Corticotropin releasing factor 2 receptor agonists
GB0209507D0 (en) Nuclear receptor structure
GB0224925D0 (en) Improved structure for carburetor
GB0321998D0 (en) Receptor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050825

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: OREGON HEALTH AND SCIENCE UNIVERSITY

A4 Supplementary search report drawn up and despatched

Effective date: 20091203

17Q First examination report despatched

Effective date: 20100507

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120127